About Prasol Chemicals IPO
Prasol Chemicals Ltd. filed a DRHP with SEBI on October 14, 2025, which is a major milestone in its debut in the Indian stock market. The Prasol Chemicals IPO is a book-built issue with a total offer amount of up to ₹500 crore, comprising a fresh issue of up to ₹80 crore equity shares and an offer for sale of up to ₹420 crore equity shares.
The price band, opening/closing dates, and final listing date will be determined by the company later. The shares are expected to be listed on the BSE and NSE trading platforms. For the Prasol Chemicals IPO, DAM Capital Advisors Ltd. is the Book Running Lead Manager (BRLM), and KFin Technologies Ltd. is the Registrar to the issue.
Company Background
Prasol Chemicals Ltd. was incorporated on January 24, 1992, as "Prachi Poly Products Private Limited." The company was headquartered in Navi Mumbai, Maharashtra. Over the years, it has had many changes and was renamed Prasol Chemicals Ltd. in 2007 to suit its growing business operations. Today, it is a diversified specialty chemicals producer with more than 30 years of experience.
The company has developed a strong presence in both the domestic and global markets. It caters to a broad range of industries, supplying necessary chemical inputs that drive the economy.
Operations and Product Range
Prasol Chemicals Ltd. mainly operates in 3 major segments of chemicals: acetone-based, phosphorus-based, and other specialty chemicals. The company is a critical part of the chemical value chain, as it has been the largest importer of acetone in India for the last 3 years (CY22-CY24) to produce a broad range of specialty chemicals. Its offerings include:
- • Acetone-based chemicals (diacetone alcohol, isophorone, and hexylene glycol).
- • Phosphorus-based chemicals (produced from yellow phosphorus, which serves the growing sectors).
The chemicals produced by Prasol Chemicals Ltd. are critical for the respective end-use industries of agrochemicals, pharmaceuticals, personal care, lubricants, and performance materials.
Facilities and Capacity
Prasol Chemicals Ltd.’s manufacturing prowess is mainly based in the state of Maharashtra, with 2 major operational facilities known as the Manufacturing Facilities, namely the Khopoli Manufacturing Facility and the Mahad Manufacturing Facility, both of which are situated in Raigad. Additionally, Prasol Chemicals Ltd. is the sole isophorone manufacturer in India, with an installed capacity of 9,000 MTPA.
Brands and Market Presence
Prasol Chemicals Ltd. has a presence spanning over three decades (30+ years), and an irreplaceable image has been built in global markets for reliability. Its market position is distinguished by its scale; it is among the top 5 importers and users of yellow phosphorus in India.
The company maintains a balanced market presence with significant export exposure, supplying its specialty chemicals to various global geographies alongside its strong domestic operations.
Revenue Streams and Business Model
The main source of revenue for Prasol Chemicals Ltd. is based on the specialty chemical products business. For Fiscal Year 2025, the revenue from operations stood at ₹1,012.49 crore.
The company is based on importing crucial raw materials such as acetone and yellow phosphorus and further processing them into specialty chemicals. This "import-to-specialty" model allows them to serve diverse industries, mitigating risks associated with being dependent on a single end-market.
Management and Shareholding
Prasol Chemicals Ltd. is led by a group of experienced promoters, including Nishith Rajnikant Shah, Gaurang Natwarlal Parikh, and Dhaval Nalin Parikh, among others. The shareholding structure before the Prasol Chemicals IPO includes a total paid-up capital of 58,000,000 equity shares. While many promoters and promoter group members are participating in the Offer for Sale (OFS).
Board and Key Management
The leadership team of Prasol Chemicals Ltd. is structured to provide both operational expertise and independent oversight by the Chairman & Whole-Time Director of the company, Nishith Rajnikant Shah and the Managing Director, Gaurang Natwarlal Parikh. The Joint Managing Director, Dhaval Nalin Parikh, manages the splitting of strategic and operational duties, and an Independent Director works to ensure robust corporate governance in the company.
Prasol Chemicals IPO Details
| Detail | Description |
|---|---|
| IPO Date | [.] |
| Listing Date | [.] |
| Face Value | ₹ 2 per Equity Share |
| Issue Price Band | [.] |
| Lot Size | [.] |
| Sale Type | Book Built Issue |
| Total Issue Size | Up to ₹ 5,000.00 million (₹500 Crore) |
| Fresh Issue(Ex Market Maker) | Up to ₹ 800.00 million (₹80 Crore) |
| Offer for Sale | Up to ₹ 4,200.00 million (₹420 Crore) |
| Issue Type | 100 % Book Built Offer |
| Listing At | BSE and NSE |
| Share Holding Pre Issue | 5,80,00,000 shares |
| Share Holding Post Issue | - |
Prasol Chemicals IPO Financial Information
Latest Revenue
233.25
₹ Crore
Profit After Tax
10.63
₹ Crore
Net Worth
378.10
₹ Crore
Total Borrowing
129.57
₹ Crore
| Period Ended | Assets | Revenue From Operations | Profit After Tax | Net Worth | Reserves & Surplus | Total Borrowing | |||
|---|---|---|---|---|---|---|---|---|---|
| 30 Jun 2025 | 534.19 | 233.25 | 10.63 | 378.10 | 366.50 | 129.57 | |||
| 31 Mar 2025 | 473.11 | 1,015.54 | 43.58 | 367.46 | 355.86 | 101.05 | |||
| 31 Mar 2024 | 424.31 | 831.06 | (30.83) | 341.28 | 329.68 | 82.07 | |||
| 31 Mar 2023 | 573.43 | 1,241.16 | 49.82 | 389.51 | 377.91 | 185.63 | |||
| Amount in ₹ Crore | |||||||||
Prasol Chemicals Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 12.57% |
| ROCE | 14.95% |
| Debt/Equity | 0.23x |
| RoNW | 11.86% |
| PAT Margin | 4.30% |
| EBITDA Margin | 8.67% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | ₹7.51 (Basic & Diluted) | [.] |
| P/E (x) | [.] | [.] |
IPO Objectives
The company planned to use the proceeds from the fresh issue of Prasol Chemicals IPO for several strategic purposes:
- • Repayment of debt (in full or in part payment) to strengthen the balance sheet of the company.
- • Funding working capital requirements to balance the financial needs of day-to-day working.
- • General corporate purposes.
Conclusion
The Prasol Chemicals IPO offers investors the chance to invest in a well-established company in the specialty chemicals market. The company has managed to create a strong business model by capitalizing on its unique position as the dominant importer and the only local producer of certain chemical compounds. As it readies itself for a public listing, its strategy continues to focus on the utilization of the new capital to further enhance its financial position.
Frequently Asked Questions
Recommended Advisory Services
Ready to take your company public? Explore our specialized IPO advisory services tailored for Indian enterprises.
The India IPO Publication is managed by an editorial team that includes highly experienced finance journalists, market researchers and professionals from the capital markets industry who strive to create high-quality content based on credible sources. Our editors write about IPOs, capital markets, corporate news, capital-raising strategies, regulations and other business matters to ensure our audience stays updated with the latest information. We conduct detailed research and fact-check all information before publishing any content to ensure credibility.
Competitive Strengths
Dominant Market Position: Producer of isophorone in India and the leading importer of acetone in the country for the production of specialty chemicals.
Diversified Industry Applications: The product range satisfies essential demands in the established and emerging segments of the pharmaceuticals, agrochemicals, and personal care industries.
Established Track Record: Over 30 years of experience in the industry with a global footprint.
| Sr.no | Description | Date | File |
|---|---|---|---|
| 1 | Filed with SEBI/Exchange | 14/10/2025 | - |
| 2 | SEBI/Exchange approval received | - | - |
Prasol Chemicals IPO Timeline
| IPO Open Date | [.] |
| IPO Close Date | [.] |
| Tentative Allotment | [.] |
| Initiation of Refunds | [.] |
| Credit of Shares to Demat | [.] |
| Tentative Listing Date | [.] |
| Cut-off time for UPI mandate confirmation | - |
IPO Lot Size
| Investors | No.of lots | Shares Offered | Max Bid Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 1 | [.] | ~₹14,000 - ₹15,000 |
| Individual investors (Retail) (Max) | 13-14 | [.] | Up to ₹2,00,000 |
| S-HNI (Min) | 14-15 | [.] | Over ₹2,00,000 |
| S-HNI (Max) | 66-70 | [.] | Up to ₹10,00,000 |
| B-HNI (Min) | 71+ | [.] | Over ₹10,00,000 |